Published in Antimicrob Agents Chemother on July 01, 2003
Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob Agents Chemother (2007) 2.05
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother (2006) 1.89
Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers. Antimicrob Agents Chemother (2009) 1.12
Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations. Antimicrob Agents Chemother (2004) 0.93
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrob Agents Chemother (2004) 0.83
Population pharmacokinetics and pharmacodynamics of garenoxacin in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother (2004) 0.82
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice. Clin Exp Nephrol (2009) 0.76
Resistance of M. leprae to quinolones: a question of relativity? PLoS Negl Trop Dis (2013) 0.75
Garenoxacin in Skin and Skin Structure Infections Sustained due to Road Traffic Accident. J Clin Diagn Res (2014) 0.75
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks. Heart Vessels (2015) 0.75
Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob Agents Chemother (2000) 3.08
In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother (1999) 2.88
Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis (1999) 2.62
Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers. Antimicrob Agents Chemother (2000) 1.80
Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother (1999) 1.75
Pharmacokinetics and pharmacodynamics of fluoroquinolones. Drugs (1999) 1.55
Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Saf (1999) 1.53
The safety profile of the fluoroquinolones. Clin Ther (2000) 1.47
Comparative antianaerobic activity of BMS 284756. Antimicrob Agents Chemother (2001) 1.44
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group. Diagn Microbiol Infect Dis (1998) 1.27
In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program. Clin Infect Dis (2000) 1.21
Expanded activity and utility of the new fluoroquinolones: a review. Clin Ther (1999) 1.19
In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae. Antimicrob Agents Chemother (2001) 1.12
Quinolone activity against anaerobes. Drugs (1999) 1.04
Toxicity of quinolones. Drugs (1999) 1.03
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci. Diagn Microbiol Infect Dis (2001) 0.95
The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance. Eur Heart J (1987) 0.92
Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males. Clin Pharmacokinet (1997) 0.88
Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration. Eur J Pharmacol (2000) 0.88
Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999). Antimicrob Agents Chemother (2001) 0.84
Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora. Clin Microbiol Infect (2002) 0.83
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades. Toxicol Appl Pharmacol (2000) 0.83
Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998). Diagn Microbiol Infect Dis (2000) 0.79
Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother (1997) 3.80
Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol (1992) 3.06
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant (2011) 2.69
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections. Antimicrob Agents Chemother (2001) 2.23
Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol (1991) 2.16
A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol (1994) 2.07
Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A (2009) 1.81
Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol (2000) 1.68
Lewis antigens in Helicobacter pylori: biosynthesis and phase variation. Mol Microbiol (2000) 1.65
Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer. Mucosal Immunol (2010) 1.59
A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect Immun (1999) 1.46
Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med (1998) 1.30
The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae. Diagn Microbiol Infect Dis (2000) 1.26
Requirement for a conserved serine in both processing and joining activities of retroviral integrase. Proc Natl Acad Sci U S A (1992) 1.20
Predictive role of capsule endoscopy on the insertion route of double-balloon enteroscopy. Endoscopy (2009) 1.19
Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. J Infect Dis (1991) 1.18
Multiple biological roles associated with the Rous sarcoma virus 5' untranslated RNA U5-IR stem and loop. J Virol (1997) 1.14
Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Comp Med (2001) 1.03
Rapid onset of ulcerative typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler's flora. Infect Immun (2006) 1.03
Age and gender effects on the pharmacokinetics of gatifloxacin. Pharmacotherapy (2000) 1.01
Nasogastric tube obstruction by Ascaris lumbricoides. Trop Doct (2002) 0.96
Comparison of osteogenesis of human embryonic stem cells within 2D and 3D culture systems. Scand J Clin Lab Invest (2008) 0.95
Pharmacometrics and the transition to model-based development. Clin Pharmacol Ther (2007) 0.92
Use of pepper crop residues for the control of root-knot nematodes. Bioresour Technol (2006) 0.90
Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br J Pharmacol (2008) 0.90
Preventive effects of perioperative parecoxib on post-discectomy pain. Br J Anaesth (2007) 0.89
Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment. Antimicrob Agents Chemother (1997) 0.88
Picture of the month. First branchial arch syndrome. Arch Pediatr Adolesc Med (1999) 0.87
Epidemiological and aetiological factors of male infertility in northern Nigeria. Niger J Clin Pract (2010) 0.87
Retroperitoneal migration of a pacemaker generator. An unusual complication. J Cardiovasc Surg (Torino) (1974) 0.85
A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men. Pharmacotherapy (2000) 0.84
Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults. Pharmacotherapy (2000) 0.84
Experimental infection in cats with a cagA+ human isolate of Helicobacter pylori. Helicobacter (1998) 0.84
Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora. Clin Microbiol Infect (2002) 0.83
Risk factors for developing pneumonia in patients with diabetes mellitus following acute ischaemic stroke. J Int Med Res (2012) 0.83
Pain relief in early rehabilitation of rotator cuff tendinitis: any role for indirect suprascapular nerve block? Eura Medicophys (2006) 0.83
Coordinate-transform technique for closed-fringe analysis by the fourier-transform method. Appl Opt (2001) 0.82
Vanishing De Vega annuloplasty for functional tricuspid regurgitation. J Thorac Cardiovasc Surg (1993) 0.81
Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects. J Antimicrob Chemother (2003) 0.80
Effects of ketamine on canine cardiovascular function. Br J Anaesth (1976) 0.80
Attenuated form of Wiskott-Aldrich syndrome. J Pediatr (1973) 0.80
AC conductivity of selectively located carbon nanotubes in poly(epsilon-caprolactone)/polylactide blend nanocomposites. Biomacromolecules (2010) 0.80
Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow. Biopharm Drug Dispos (1987) 0.79
Physical and biochemical characteristics of platelets in severely malnourished children with purpura. Scand J Haematol (1971) 0.79
Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system. Clin Pharmacol Ther (2007) 0.79
Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise. Pharmacotherapy (2000) 0.79
Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients. Eur J Clin Pharmacol (1991) 0.79
Glasgow Coma Scale, brain electric activity mapping and Glasgow Outcome Scale after hyperbaric oxygen treatment of severe brain injury. Chin J Traumatol (2001) 0.79
Inhibitory and facilitatory effects of cue onset and offset. Psychol Res (1998) 0.78
Metabolism of (-)-(S)-nicotine in the isolated perfused rabbit lung. Eur J Drug Metab Pharmacokinet (1998) 0.78
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients. Eur J Clin Pharmacol (1993) 0.78
Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin. J Chemother (2003) 0.78
Effect of sodium bicarbonate on canine left ventricular function. Angiology (1977) 0.78
Rapid and complete decompression of chronic urinary retention: a safe and effective practice. Trop Doct (2013) 0.78
The role of intra-luteal factors in the control of the porcine corpus luteum. Soc Reprod Fertil Suppl (2006) 0.77
An additional strip of mesh minimizes hernia recurrence after laparoscopic totally extraperitoneal (TEP) inguinal hernia repair. An analysis of 490 cases over 10 years. Minerva Chir (2014) 0.77
A clinical trial of an oral urea preparation (Carbamine) in peptic ulcer therapy. Ir J Med Sci (1968) 0.77
Insulin-like growth factor (IGF)-I, IGF-I receptor, and IGF binding protein-3 messenger ribonucleic acids and protein in corpora lutea from prostaglandin F(2alpha)-treated gilts. Biol Reprod (1999) 0.77
Clinical, brain electric earth map, endothelin and transcranial ultrasonic Doppler findings after hyperbaric oxygen treatment for severe brain injury. Chin Med J (Engl) (2001) 0.77
Low incidence of myotonic dystrophy in Chinese Hans is associated with a lower number of CTG trinucleotide repeats. Am J Med Genet (2000) 0.77
Deoxyspergualin: mechanism of action and pharmacokinetics. Transplant Proc (1996) 0.77
Evolving concepts of chondrogenic differentiation: history, state-of-the-art and future perspectives. Eur Cell Mater (2015) 0.77
[Antibiotic pretreatment of heart valve prostheses]. Minerva Cardioangiol (1992) 0.76
Performance enhancement of fluorescence energy transfer-based biosensors by site-directed mutagenesis of the transducer. J Biomed Opt (1996) 0.76
Clostridium piliforme infection in two farm-raised white-tailed deer fawns (Odocoileus virginianus) and association with copper toxicosis. Vet Pathol (2006) 0.76
[Hemoglobin D Punjab in a Mexican family with 2 clinical cases of hemoglobinopathy S-D]. Rev Invest Clin (1971) 0.76
Steroidogenic responses of pig corpora lutea to insulin-like growth factor I (IGF-I) throughout the oestrous cycle. Reproduction (2003) 0.76
[Direct surgery of coronary disease and post-infarction outcomes]. Boll Soc Ital Cardiol (1972) 0.75
[Hemostasis tests in the neonatal period. I. Prothrombin time in the capillary blood of the newborn infant and the hematocrit during the 1st 24 hours of life]. Bol Med Hosp Infant Mex (1986) 0.75
[Hypoplastic anemia in the pediatric age]. Bol Med Hosp Infant Mex (1983) 0.75
[Clinical analysis of 36 patients with blood diseases treated with cord blood hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi (2017) 0.75
Surgical treatment of the aneurysms of the descending thoracic aorta. A study of 14 cases. J Cardiovasc Surg (Torino) (1972) 0.75
Comparative experience with endocardial and epicardial pacemakers. J Cardiovasc Surg (Torino) (1975) 0.75
Ascending aorta-right pulmonary artery anastomosis in children with complex cardiac malformations. Long-term results in 30 cases. J Thorac Cardiovasc Surg (1975) 0.75
[Results in 132 patients operated for aortic defects]. Boll Soc Ital Cardiol (1972) 0.75
[Modified technic for the total correction of transposition of the great vessels]. Minerva Med (1973) 0.75
[The clinical problem of hereditary hemorrhagic diseases developing prolonged bleeding time]. Bol Med Hosp Infant Mex (1975) 0.75
The use of a permanent pacemaker for ventricular tachiarrhythmia without atrio-ventricular block. J Cardiovasc Surg (Torino) (1972) 0.75
Permanent cardiac pacing experience with arrhythmias caused by Chagas' disease and other cardiopathies. J Cardiovasc Surg (Torino) (1973) 0.75
Hot cutting of goat carcasses following early post-mortem high temperature ageing. Meat Sci (1986) 0.75
[504 implantations of aortic valve prostheses]. Minerva Med (1979) 0.75
Complications in open heart surgery. Analysis of 350 patients. J Cardiovasc Surg (Torino) (1970) 0.75
[Iron deficiency in childhood: a public health problem]. Bol Med Hosp Infant Mex (1987) 0.75
[Ventricular asynergy. Coronarographic and ventriculographic study]. Boll Soc Ital Cardiol (1972) 0.75
[Hemolytic anemia caused by enzymatic defects of rare erythrocytes]. Gac Med Mex (1976) 0.75
[Therapy with gentamicin in patients operated for heart diseases. Preliminary note]. Minerva Med (1973) 0.75
[Effectiveness of topical selective decontamination, without systemic antibiotic prophylaxis, in prevention of pulmonary infection in intensive care]. Minerva Anestesiol (1990) 0.75
[Infant nutrition. IV. Viscosity metamorphosis and blood platelet adhesiveness in children with severe malnutrion]. Gac Med Mex (1967) 0.75
[Iatrogenic disease in hemophilia and Von Willebrand's disease]. Bol Med Hosp Infant Mex (1982) 0.75
Country watch: Dominican Republic. AIDS Health Promot Exch (1992) 0.75
[Radical correction of the tetralogy of Fallot: 122 cases]. Minerva Med (1979) 0.75
Effect of 4-aminopyridine on cardiovascular functions in the dog. Can Anaesth Soc J (1981) 0.75
[Modified technic for total correction of transposition of great vessels]. Minerva Med (1973) 0.75
[Diagnostic problems related to toxoplasmic infections. Evaluation of specific immunoglobulins by immunoadsorption as compared with other methods]. Quad Sclavo Diagn (1981) 0.75
[Case of imperforation of the pulmonary valve]. Minerva Med (1972) 0.75
[Surgery of ventricular aneurysms and akinetic zones]. Minerva Med (1979) 0.75
[Megaloblastic anemia in the recovery of the malnourished child]. Bol Med Hosp Infant Mex (1976) 0.75
[Encephalo-trigeminal angiomatosis (Sturge-Weber): an advanced form]. Riv Neurobiol (1983) 0.75